Upstream processing advancements are driving higher yields and increasing batch volumes, placing growing strain on downstream operations—particularly in buffer preparation and management. Biologics manufacturers are thus turning to mitigation strategies, such as strategic outsourcing, to improve efficiency and scalability. Shifting the production of high-volume buffers to external suppliers can reduce storage burdens, enhance operational flexibility, and free internal capacity for process-specific activities.
Learn more about the benefits of buffer outsourcing in this application note from Thermo Fisher Scientific!